New book shows how one continuous glucose monitor helped reverse a Type 2 diabetes diagnosis in three months — and how ...

Wellness trends are leading people who don’t have diabetes to buy continuous glucose monitors as a healthcare wearable. Hanan Hammad reports For people with diabetes, continuous glucose monitors (CGMs ...

Remote continuous glucose monitoring systems have been added to the "white list" of sites that are accessible when the mobile ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet ...

Around 1.2 million Australians live with type 2 diabetes, yet there is no government subsidy for CGMs, despite this being well-established ...

Until now. Backed by more than six years of dedicated research and development in biosensing technology, Ottai has released a ...

Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of ...

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...

Whoop announced that it raised $575 million in a Series G financing round with medtech giant Abbott taking part.

Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...

Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the ...